Pulmonary Systemic Sclerosis — Clinical Trials

MONDO:00020472 active·1 recruitingLast updated: Mar 20, 2026, 8:23 AM

Pulmonary Systemic Sclerosis has an emerging clinical trial program, driven by drug treatment.

Recruiting

Active Trials

Drug Treatment2

1 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

Phase 2

Phase 3

Academic/Other2

Canada1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

2 Trials

Phase 2Recruiting

Sponsor:Centre hospitalier de l'Université de Montréal (CHUM)

CanadaStarted: Aug 2024Est. completion: Dec 2028Updated: Apr 2025

Phase 3Not Yet Recruiting

Sponsor:University Hospital, Tours

Started: Nov 2024Est. completion: Nov 2028Updated: Aug 2024

Last updated over 18 months ago

Stay informed about clinical trials for Pulmonary Systemic Sclerosis.

Follow this disease to get updates when trials open, close, or change status.

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 20, 2026 at 8:23 AM